ER/LA Opioid REMS: Achieving Safe Use While Improving Patient Care

Des Moines, IA US
May 2, 2015

This educational activity is a part of the Iowa Osteopathic Medical Society Upper Midwest Osteopathic Health Conference. 

To attend, you must register for the conference by clicking here

Almost 75% of prescription drug overdose deaths are caused by prescription opioids, more than cocaine and heroin combined.

As a prescriber, do you know the best strategy for prescribing opioids? Practicing physicians often struggle to manage their patients’ pain. Extended-release (ER) and long-acting (LA) opioids are a valuable element of the pain management plan for some patients. Unfortunately, the misuse and abuse of ER/LA opioids have resulted in a serious public health crisis of addiction, overdose, and death. Clinicians must play a role in prevention. The U.S. Food and Drug Administration has announced a risk evaluation and mitigation strategy (REMS) for ER/LA opioid products.


This program is presented by the American Osteopathic Association, a member of the Collaborative on REMS Education (CO*RE), ten interdisciplinary organizations working together to improve pain management and prevent adverse outcomes.

RPC Commercial Support Disclosure Statement

This educational activity is supported by an independent educational grant from the ER/LA Opioid Analgesic REMS Program Companies (RPC). Please see for a listing of the member companies. This activity is intended to be fully-compliant with the ER/LA Opioid Analgesic REMS education requirements issued by the U.S. Food & Drug Administration (FDA).

Target Audience


Learning Objectives

  1. Describe appropriate patient assessment for treatment with ER/LA opioid analgesics, evaluating risks and potential benefits of ER/LA therapy as well as possible misuse.
  2. Apply proper methods to initiate therapy, modify dose, and discontinue use of ER/LA opioid analgesics, applying best practices including accurate dosing and conversion techniques as well as appropriate discontinuation strategies.
  3. Demonstrate accurate knowledge about how to manage ongoing therapy with ER/LA opioid analgesics and properly use evidence-based tools while assessing for adverse effects.
  4. Employ methods to counsel patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
  5. Review/assess general and product-specific drug information concerning ER/LA opioid analgesics and identifying potential adverse effects of ER/LA opioids.
Course summary
Course opens: 
Course expires: 
Event starts: 
05/02/2015 - 2:00pm CDT
Event ends: 
05/02/2015 - 4:00pm CDT
Embassy Suites
101 E. Locust Street
Des Moines, IA 50309
United States

Annette T. Carron, DO, CMD, FACOI, FAAHPM 

Director of Geriatrics and Palliative Care, Botsford Hospital, Farmington Hills, MI
Assistant Clinical Professor, Internal Medicine, Michigan State University College of Osteopathic Medicine

Dr. Carron serves as director of Geriatrics and Palliative Care at Botsford Hospital in Farmington Hills, MI. She previously served for six years as director of Beaumont Hospital’s Palliative Medicine program. Dr. Carron has also practiced in long-term care for 14 years. She is a certified medical director, certified in hospice and palliative medicine and recently awarded fellowship in the American Academy of Hospice and Palliative Medicine. Dr. Carron also is board certified in Internal Medicine and Geriatrics. She serves on a hospital-wide pain committee in the role of physician education. She has spoken frequently on pain management, hospice and palliative care, including helping present the American Medical Association Educating Physicians on End-of-Life Care (EPEC) curriculum. Dr. Carron is also Assistant Clinical Professor Internal Medicine at Michigan State University College of Osteopathic Medicine and serves as board member and chair of the Palliative Medicine subsection of the American College of Osteopathic Internists.

Everyone in a position to control the content of this educational activity will disclose to the CME provider and to attendees all relevant financial relationships with any commercial interest. Des Moines University (DMU) prohibits discrimination in a person’s race, color, national origin, ethnicity, creed, religion, age, disability, sex, gender identity, sexual orientation, veteran status, genetic information and other characteristics protected by law (“protected class”). The University also affirms its commitment to providing equal opportunities and equal access to University facilities. Individuals with disabilities are encouraged to attend DMU sponsored activities. You are able to access DMUs legal information here. If you have questions/concerns, please contact the DMU CME office at 515-271-1596 or


Please login or Create an Account to take this course.